ArticleJournal of assisted reproduction and genetics2026
Fertility preservation with successful pregnancy outcome in a young patient with endometrial cancer.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rising incidence of endometrial cancer (EC) in young women presents a significant challenge in balancing oncologic safety with fertility preservation. While fertility-sparing treatment is an option for carefully selected patients with early-stage, well-differentiated EC, management of recurrence and optimization of fertility outcomes remain complex. CASE PRESENTATION: A 33-year-old nulliparous woman was diagnosed with Grade 1 endometrioid adenocarcinoma confined to the endometrium (ER/PR positive). After multidisciplinary team (MDT) evaluation confirmed eligibility, she received first-line high-dose progestin therapy. Complete remission (CR) was achieved and confirmed by hysteroscopy at 3 months, followed by 3 months of consolidation therapy. During preparation for embryo transfer after successful oocyte retrieval via a progestin-primed ovarian stimulation (PPOS) protocol, recurrence was detected hysteroscopically. Retreatment with the same progestin regimen led to a second CR after 6 months. Subsequently, a thawed embryo transfer resulted in a successful pregnancy, culminating in the delivery of a healthy infant at term.
conclusionThis case suggests that successful fertility preservation and live birth may be achievable in young patients with early-stage EC when a structured approach is applied-including strict MDT selection, standardized progestin therapy with diligent surveillance, proactive management of recurrence, and well-timed assisted reproductive technology (ART). Notably, repeat conservative treatment for localized recurrence was successfully employed in this patient. Integrating weight management and comprehensive molecular profiling into future treatment paradigms could further optimize outcomes, but these observations require validation in larger cohorts.
Indexed as
Identifiers
42402541What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.